Pin13 Estimating the Impact of a Gender-Neutral Quadrivalent Human Papillomavirus Vaccination Program in All HPV 6/11/16/18 -Related Diseases in Colombia

Carrasquilla, M.; Alvis-Zakzuk, Nelson J.; Sierra, Javier; Rosa, F. Gómez De la; Beltrán, Carmen Natividad Cárdenas; Rojas, Mary; Prieto, E.; Yen, Glorian P.; Parellada, C.; Pavelyev, A.; Monsanto, H; Hoz, Fernando de la; Zakzuk, N.R. Alvis

doi:10.1016/j.jval.2020.04.489

Value in Health

2020

DOI: 10.1016/j.jval.2020.04.489

|View full text |Cite

Pin13 Estimating the Impact of a Gender-Neutral Quadrivalent Human Papillomavirus Vaccination Program in All HPV 6/11/16/18 -Related Diseases in Colombia

M. Carrasquilla¹,

Nelson J. Alvis-Zakzuk

Javier Sierra³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Socioeconomic and fiscal returns of expanded investment in immunization: a case for life-course vaccination in Colombia

Soto-Moreno,

Coe,

Parellada

et al. 2024

Health Affairs Scholar

View full text Add to dashboard Cite

Despite the health, societal, and economic benefits of immunization, many countries focus primarily on childhood immunizations and lack robust policies and sufficient resources for immunizations that can benefit populations across the life course. While the benefits of childhood vaccination are well documented, there is limited evidence on the financial and social return on investment that policymakers can use to inform decisions around administering a life-course immunization program. We developed a cost-benefit model from a societal perspective to evaluate the inclusion of 5 vaccines across the life course in Colombia's national immunization program. This model estimated a return of US$1.3 per US$1.0 invested in the first 2 decades, increasing to US$3.9 after 60 years. Primary benefits were productivity gains, followed by fiscal savings and household averted expenditure on health care. Furthermore, vulnerable households are predicted to receive 3.2 times greater income protection than formally employed households under a life-course immunization program. Consequently, there is a potential to reduce Colombia's income inequality and poverty rate by increasing access to immunization for all ages.

show abstract

Socioeconomic and fiscal returns of expanded investment in immunization: a case for life-course vaccination in Colombia

Soto-Moreno,

Coe,

Parellada

et al. 2024

Health Affairs Scholar

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Pin13 Estimating the Impact of a Gender-Neutral Quadrivalent Human Papillomavirus Vaccination Program in All HPV 6/11/16/18 -Related Diseases in Colombia

Cited by 1 publication

References 0 publications

Socioeconomic and fiscal returns of expanded investment in immunization: a case for life-course vaccination in Colombia

Socioeconomic and fiscal returns of expanded investment in immunization: a case for life-course vaccination in Colombia

Contact Info

Product

Resources

About